Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York. Show more

Location: 27 West 24th Street, New York, NY, 10010, United States | Website: https://www.tourmalinebio.com | Industry: Biotechnology | Sector: Healthcare

Market Cap

476.8M

52 Wk Range

$11.56 - $29.79

Previous Close

$18.96

Open

$19.09

Volume

113,467

Day Range

$18.33 - $19.22

Enterprise Value

161.6M

Cash

249.3M

Avg Qtr Burn

-21.0M

Insider Ownership

21.93%

Institutional Own.

90.10%

Qtr Updated

03/31/25

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Pacibekitug (TOUR006) Details Thyroid Eye Disease	Phase 2b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Pacibekitug (TOUR006) Details Atherosclerotic cardiovascular disease (ASCVD)	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FCR001 Details Scleroderma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.